Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Non-small cell lung cancer | R-HSA-5619066 | map05223 | nalidixic acid | 9903 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | nalidixic acid | 9903 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | nalidixic acid | 9903 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | nalidixic acid | 9903 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | nalidixic acid | 9903 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | nalidixic acid | 9903 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | nalidixic acid | 9903 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | nalidixic acid | 9903 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | nalidixic acid | 9903 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | nalidixic acid | 9903 | drug-path |
| Small cell lung cancer | R-HSA-5619066 | map05222 | nalidixic acid | 9903 | drug-path |
| Taste transduction | R-HSA-162582 | map04742 | metaraminol | 5906 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | metaraminol | 5906 | drug-path |
| Long-term depression | R-HSA-9620244 | map04730 | metaraminol | 5906 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | metaraminol | 5906 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | metaraminol | 5906 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | metaraminol | 5906 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | metaraminol | 5906 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | metaraminol | 5906 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | cefamandole | 4421 | drug-path |